Skip Navigation LinksHome > Professional Development > AABB US Hemovigilance Symposium

AABB US Hemovigilance Symposium

​Feb 13-14, 2017

 

Printable Registration Form

Event Description

AABB US Hemovigilance Symposium is the first of what is intended to become an annual event to bring together experts from the United States and around the world to discuss progress in US hemovigilance. Experts will address the state of US hemovigilance, recognizing the successes of the past 10 years, identify challenges such as perceived barriers to participation, and share recommendations for future improvement and harmonization.

Learning Objectives

  1. Describe the current process for reporting adverse transfusion related events in the US.
  2. Discuss international hemovigilance programs and how they differ from those in the US.
  3. Review current infectious risks associated with blood safety and the latest surveillance programs addressing these risks.
  4. Describe approaches to donor health and safety through hemovigilance and blood center driven safety activities.
  5. Learn about the challenges to hemovigilance in the US, including event reporting strategies used by different types of hospitals.
  6. Describe existing and perceived barriers to participation in hemovigilance programs and approaches for increasing participation.

Agenda

Day 1

1:00 pm Meeting Opening
AABB Hemovigilance Committee Chair: Mark Fung, MD, PhD (UVM)
  Value, Purpose and Vision of Hemovigilance: Where We’ve Been and Where We Can Be Going
Keynote speaker: Harvey Klein, MD (NIH)
1:30 pm Hemovigilance Throughout the Globe
  • Paula Bolton-Maggs, DM, FRCP, FRCPath (United Kingdom)
  • Philippe Renaudier, MD, MPH (France)
  • Nancy Heddle, MSc, FCSMLS(D) (Canada)
3:00 pm Break
3:30 pm State of US Hemovigilance: Taking Stock of Accomplishments
Moderator: Michael Murphy, MD, FRCP, FRCPath, FFPath
  • Kathryn Haass, MPH, CPH, MT(AAB), BB(ASCP)CMM (CDC)
  • Steven Anderson, PhD, MPP (FDA)
  • Melissa Cumming, MS (Massachusetts Department of Public Health)
  • Ross Herron, MD (American Red Cross)
  • Barbee Whitaker, PhD (AABB Center for Patient Safety)
5:30 pm Panel Discussion
6:00 pm Adjourn

Day 2

8:30 am Hemovigilance Relating to Donors and Starting Material
Moderator: Steven Anderson, PhD, MPP (FDA)  
  Donor Hemovigilance: Blood Collectors Pioneering the Way
Donor Vigilance, DonorHART and Gaps in Donor Health and Safety
James Stubbs, MD (Mayo Clinic)
  Infectious Risks
  • REDS-III Hemovigilance – Brian Custer, PhD, MPH (Blood Systems)
  • Transfusion-Transmissible Infections Monitoring System (TTIMS) Steering Committee
    • Brian Custer, PhD, MPH
    • Susan Stramer, PhD
  • Hemovigilance and Impact of Pathogen Reduction - Laurence Corash. MD (Cerus)
10:30 am Challenges to US Hemovigilance I: Approaches to Data Validation and Verification
Moderator: James P. AuBuchon, MD, FCAP, FRCP (Edin)
  • Nancy Heddle, MSc, FCSMLS(D) (McMaster University)  
  • Paula Bolton-Maggs, DM, FRCP, FRCPath (UK SHOT)
  • Philippe Renaudier, MD, MPH (France)
  • Barbee Whitaker, PhD (AABB CPS)
  • Panel Discussion Q&A
11:30 am Practical Hemovigilance: Local Approaches and Challenges to Managing Hemovigilance
Moderator: Yanyun Wu, MD 
  • James Stubbs, MD (Mayo)
  • Pampee Young, MD, PhD (Vanderbilt)
12:30 - 1:15 pm LUNCH
1:15 pm Challenges to US Hemovigilance II: Existing and Perceived Barriers to Participation
Moderator: Barbee Whitaker, PhD
  • Pampee Young, MD, PhD (Hospital perspective)
  • Misha Baker, MPH (CDC)
  • Mark Fung, MD, PhD (Private sector perspective)
  • Paula Bolton-Maggs, DM, FRCP, FRCPath (International perspective)
  • Panel Discussion Q&A
2:45 pm Concluding Statements and Open Comments from Audience
AABB Hemovigilance Committee Chair: Mark Fung, MD, PhD
3:00 pm Adjourn

Event Level

Intermediate

Continuing Education Information

Physicians

AABB is an approved, and accredited provider (Provider Number 0000381) by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AABB designates these educational activities for a maximum of 9.75 credit hours in Category 1 credits toward the AMA Physicians Recognition AwardTM. Each physician should claim only those credits that he/she actually spent in the activity.

Florida Clinical Laboratory Personnel

AABB is approved by the Florida Board of Clinical Laboratory Personnel, Provider Number 50-4261-1, as a provider of continuing education programs for Florida-licensed clinical laboratory personnel. This event has been approved for a maximum of 11.75 contact hours.

California Clinical Laboratory Personnel

AABB is an approved accrediting agency for continuing education for California licensed clinical laboratory personnel. This event has been approved for a maximum of 11.75 contact hours. AABB’s accrediting agency number is 0011. Credit earned through attendance at this event may be used to fulfill the state requirement for continuing education hours to maintain licensure status.

California Nurses

AABB is approved by the California Board of Registered Nursing, Provider Number 4341, as a provider of continuing nursing education programs. AABB designates this event for a maximum of 9.75 contact hours.

ASCP-Certified Professionals

All AABB educational programs are ACCME accredited and satisfy the “formal education” option of the American Society of Clinical Pathologists (ASCP) Certification Maintenance Program (CMP).

General Attendees

Administrators, laboratory personnel, nurses (non-California) and general attendees may receive a certificate of attendance for participation in this event. This certificate verifies attendance at the conference.

Registration Fees

FREE
Due to the generous educational grant from Cerus, the event is free for the first 100 people.

Location

Loews Atlanta Hotel
1065 Peachtree St, NE
Atlanta, GA 30309

Book online.

Book by phone +1.888.563.9736.
Please mention AABB Hemovigilance Symposium when booking by phone.

Rate: $219.00/night

The event room rate expires on January 18, 2017. Starting January 19, AABB cannot guarantee the event room rate.

Audience

Physicians, Scientists, Technologists, Nurses, Managers/Supervisors

Supported by Cerus.